{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T00:09:16Z","timestamp":1794096556182,"version":"4.8.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002842","name":"Chiang Mai University","doi-asserted-by":"publisher","award":["38\/2566"],"award-info":[{"award-number":["38\/2566"]}],"id":[{"id":"10.13039\/501100002842","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.pnpbp.2024.110985","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T12:14:37Z","timestamp":1709036077000},"page":"110985","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Efficacy and acceptability of S-adenosyl-L-methionine (SAMe) for depressed patients: A systematic review and meta- analysis"],"prefix":"10.1016","volume":"132","author":[{"given":"Nahathai","family":"Limveeraprajak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirapop","family":"Nakhawatchana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apidsada","family":"Visukamol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christsanutth","family":"Siripakkaphant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirijit","family":"Suttajit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manit","family":"Srisurapanont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2024.110985_bb0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0022-3956(76)90008-X","article-title":"Effect of s-adenosyl-l-methionine (SAMe) upon depressive symptoms","volume":"13","author":"Agnoli","year":"1976","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid. Based Ment. Health"},{"key":"10.1016\/j.pnpbp.2024.110985_bb0015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-0404.1994.tb05404.x","article-title":"S-adenosylmethionine blood levels in major depression: changes with drug treatment","volume":"154","author":"Bell","year":"1994","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0025","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0165-1781(92)90029-3","article-title":"Efficacy of S-adenosyl-L-methionine in speeding the onset of action of imipramine","volume":"44","author":"Berlanga","year":"1992","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0030","doi-asserted-by":"crossref","first-page":"1151S","DOI":"10.1093\/ajcn\/76.5.1151S","article-title":"S-Adenosyl-L-methionine (SAMe): from the bench to the bedside--molecular basis of a pleiotrophic molecule","volume":"76","author":"Bottiglieri","year":"2002","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0035","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s40360-020-00466-7","article-title":"Pharmacokinetic study of a novel oral formulation of S-adenosylmethionine (MSI-195) in healthy subjects: dose escalation, food effect and comparison to a commercial nutritional supplement product","volume":"21","author":"Cameron","year":"2020","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0040","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00002826-198608000-00005","article-title":"Affective illness and S-adenosyl methionine: a preliminary report","volume":"9","author":"Carney","year":"1986","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0045","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0140-6736(84)91360-6","article-title":"Antidepressant activity of S-adenosylmethionine","volume":"1","author":"Caruso","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2024.110985_bb0050","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(21)02143-7","article-title":"Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic","volume":"398","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2024.110985_bb0055","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/jmwh.13527","article-title":"Treatment of mood and depressive disorders with complementary and alternative medicine: efficacy review","volume":"68","author":"Cutler","year":"2023","journal-title":"J. Midwifery Womens Health"},{"key":"10.1016\/j.pnpbp.2024.110985_bb0060","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/1871527314666150821103825","article-title":"A comprehensive review on the efficacy of S-Adenosyl-L-methionine in major depressive disorder","volume":"15","author":"De Berardis","year":"2016","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.pnpbp.2024.110985_bb0065","first-page":"52","article-title":"Oral S-adenosyl-L-methionine in depression","author":"De Vanna","year":"1992","journal-title":"Curr. Ther. Res. - Clin. Exp."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0070","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f2304","article-title":"Influence of trial sample size on treatment effect estimates: meta-epidemiological study","volume":"346","author":"Dechartres","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.pnpbp.2024.110985_bb0075","doi-asserted-by":"crossref","first-page":"1172S","DOI":"10.1093\/ajcn\/76.5.1172S","article-title":"Efficacy and tolerability of oral and intramuscular S-adenosyl-L-methionine 1,4-butanedisulfonate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicenter studies","volume":"76","author":"Delle Chiaie","year":"2002","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0080","series-title":"SAM-e for the Treatment of Depression in Patients with Parkinson\u2019s Disease ClinicalTrials.gov identifier: NCT00070941 [WWW document]","author":"Di Rocco","year":"2003"},{"key":"10.1016\/j.pnpbp.2024.110985_bb0085","first-page":"140","article-title":"The effects of S-adenosyl-L-methionine-vitamin B complex on mild and moderate depressive symptoms","volume":"21","author":"Djokic","year":"2017","journal-title":"Hippokratia"},{"key":"10.1016\/j.pnpbp.2024.110985_bb0090","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/15622975.2020.1851052","article-title":"A clinical approach to treatment resistance in depressed patients: what to do when the usual treatments don\u2019t work well enough? World J. Biol. Psychiatry off","volume":"22","author":"Dodd","year":"2021","journal-title":"J. World Fed. Soc. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.110985_bb0095","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.eurpsy.2011.01.003","article-title":"SAMe and sexual functioning","volume":"27","author":"Dording","year":"2012","journal-title":"Eur. Psychiatr."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1600-0447.1992.tb03223.x","article-title":"The thyrotropin response to thyrotropin-releasing hormone as a predictor of response to treatment in depressed outpatients","volume":"86","author":"Fava","year":"1992","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0105","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s42003-022-03280-5","article-title":"Excess S-adenosylmethionine inhibits methylation via catabolism to adenine","volume":"5","author":"Fukumoto","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0110","article-title":"S-adenosyl methionine (SAMe) for depression in adults","volume":"10","author":"Galizia","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0115","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s13311-017-0593-0","article-title":"S-adenosyl methionine and transmethylation pathways in neuropsychiatric diseases throughout life","volume":"15","author":"Gao","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pnpbp.2024.110985_bb0120","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.pnpbp.2024.110985_bb0125","series-title":"Cochrane Handbook for Systematic Reviews of Interventions, 2nd","author":"Higgins","year":"2019"},{"key":"10.1016\/j.pnpbp.2024.110985_bb0130","doi-asserted-by":"crossref","first-page":"244","DOI":"10.5152\/alphapsychiatry.2023.231358","article-title":"Ketamine and electroconvulsive therapy for treatment-refractory depression","volume":"24","author":"Huang","year":"2023","journal-title":"Alpha Psychiat."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0135","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1176\/ajp.147.5.591","article-title":"Oral S-adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial","volume":"147","author":"Kagan","year":"1990","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.110985_bb0140","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jad.2011.04.059","article-title":"Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder","volume":"136","author":"Levkovitz","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0145","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1357-2725(99)00139-9","article-title":"S-Adenosylmethionine","volume":"32","author":"Lu","year":"2000","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0150","series-title":"MKinfer: Inferential Statistics (Version 1.1)","author":"Matthias","year":"2023"},{"key":"10.1016\/j.pnpbp.2024.110985_bb0155","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4088\/JCP.13m08591","article-title":"A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorder","volume":"75","author":"Mischoulon","year":"2014","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0160","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/MEG.0000000000001141","article-title":"Chronic liver diseases and the potential use of S-adenosyl-L-methionine as a hepatoprotector","volume":"30","author":"Mora","year":"2018","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0165","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.pnpbp.2024.110985_bb0170","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1017\/S1461145702003085","article-title":"A double-blind, randomized parallel-group, efficacy and safety study of intramuscular S-adenosyl-L-methionine 1,4-butanedisulphonate (SAMe) versus imipramine in patients with major depressive disorder","volume":"5","author":"Pancheri","year":"2002","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0175","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1176\/appi.ajp.2009.09081198","article-title":"S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial","volume":"167","author":"Papakostas","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.110985_bb0180","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2023"},{"key":"10.1016\/j.pnpbp.2024.110985_bb0185","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/0706743716660290","article-title":"Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the Management of Adults with major depressive disorder: section 5. Complementary and alternative medicine treatments","volume":"61","author":"Ravindran","year":"2016","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0190","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1176\/appi.ajp.2018.18040398","article-title":"Improving depression outcome by patient-centered medical management","volume":"175","author":"Rush","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.110985_bb0195","article-title":"Oral administration of S-Adenosylmethionine (SAMe) and lactobacillus Plantarum HEAL9 improves the mild-to-moderate symptoms of depression: a randomized, double-blind, placebo-controlled study","volume":"22","author":"Saccarello","year":"2020","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0200","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000288642","article-title":"Double-blind, placebo-controlled study of S-adenosyl-L-methionine in depressed postmenopausal women","volume":"59","author":"Salmaggi","year":"1993","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0205","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-0035-1549928","article-title":"Is S-Adenosyl methionine (SAMe) for depression only effective in males? A re-analysis of data from a randomized clinical trial","volume":"48","author":"Sarris","year":"2015","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pnpbp.2024.110985_bb0210","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1176\/appi.ajp.2016.15091228","article-title":"Adjunctive nutraceuticals for depression: a systematic review and Meta-analyses","volume":"173","author":"Sarris","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.110985_bb0215","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.euroneuro.2018.07.098","article-title":"Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: an 8-week double-blind, randomized, controlled trial","volume":"28","author":"Sarris","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0220","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jad.2018.11.092","article-title":"Nutraceuticals for major depressive disorder- more is not merrier: an 8-week double-blind, randomised, controlled trial","volume":"245","author":"Sarris","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0225","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/15622975.2021.2013041","article-title":"Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: the world Federation of Societies of biological psychiatry (WFSBP) and Canadian network for mood and anxiety treatments (CANMAT) taskforce","volume":"23","author":"Sarris","year":"2022","journal-title":"World J. Biol. Psychiat. Off J. World Fed. Soc. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.110985_bb0230","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/02698811221104058","article-title":"Systematic review and meta-analysis of augmentation and combination treatments for early-stage treatment-resistant depression","volume":"37","author":"Scott","year":"2023","journal-title":"J. Psychopharmacol. Oxf. Engl."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0235","first-page":"19","article-title":"Noninferiority trials","volume":"1","author":"Snapinn","year":"2000","journal-title":"Curr. Control. Trials Cardiovasc. Med."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0240","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.pnpbp.2024.110985_bb0245","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jpsychires.2019.11.014","article-title":"Early score fluctuation and placebo response in a study of major depressive disorder","volume":"121","author":"Targum","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0250","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.mulmdd3048sho","article-title":"Have effective antidepressants finally arrived? Developments in major depressive disorder therapy","volume":"84","author":"Thase","year":"2023","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0255","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00004850-198704000-00001","article-title":"The influence of S-adenosylmethionine (SAM) on prolactin in depressed patients","volume":"2","author":"Thomas","year":"1987","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0260","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jclinepi.2019.11.014","article-title":"An observational study of missing data inquiry from randomized trial authors showed a poor response","volume":"119","author":"Tsokani","year":"2020","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.pnpbp.2024.110985_bb0265","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.3390\/nu14132751","article-title":"The efficacy of S-Adenosyl methionine and probiotic supplementation on depression: a synergistic approach","volume":"14","author":"Ullah","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.pnpbp.2024.110985_bb0270","doi-asserted-by":"crossref","first-page":"270","DOI":"10.5152\/alphapsychiatry.2023.231401","article-title":"Optimization strategies of transcranial magnetic stimulation in major depressive disorder","volume":"24","author":"Wen","year":"2023","journal-title":"Alpha Psychiat."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624000538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624000538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T10:42:22Z","timestamp":1777545742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584624000538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":54,"alternative-id":["S0278584624000538"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.110985","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and acceptability of S-adenosyl-L-methionine (SAMe) for depressed patients: A systematic review and meta- analysis","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.110985","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110985"}}